Is Amcor Stock Underperforming the S&P 500?

Headquartered successful Zurich, Switzerland, Amcor plc (AMCR) delivers packaging solutions for user and healthcare markets, emphasizing sustainability crossed flexible and rigid formats. With a marketplace capitalization of nearly $19 billion, good supra the $10 cardinal “large-cap” threshold, the institution serves planetary food, beverage, medical, pharmaceutical, and idiosyncratic attraction industries.

Despite this scale, AMCR banal is presently trading 21.2% beneath its March precocious of $10.45 and has slipped modestly implicit the past 3 months. Over the aforesaid period, the S&P 500 Index ($SPX) advanced 3.7%, highlighting wide comparative underperformance.

• Inflation Data, AI Earnings and Other Can't Miss Items this Week

• How to Make a 1.77% 1-Month Yield successful GOOGL Stock - It Still Looks Undervalued

• Is IBM the Top Tech Stock to Buy for 2026?

• Tired of missing midday reversals? The FREE Barchart Brief newsletter keeps you successful the know. Sign up now!

The comparative weakness becomes much pronounced implicit longer horizons. AMCR declined 17.6% implicit the past 52 weeks and fell different 12.5% year-to-date (YTD). These losses basal successful stark opposition to the S&P 500’s respective gains of 12.8% and 16.1%, underscoring sustained sentiment pressure.

Technically, the terms enactment reinforces that caution. The banal has remained beneath its 200-day moving mean of $8.95 since mid-August, repeatedly failing astatine that declining inclination line. Although AMCR banal concisely reclaimed its 50-day mean of $8.23 successful Nov, the pullback successful Dec reversed that progress, leaving the near-term inclination weak.

Fundamentals, however, person begun to stabilize expectations. On Nov 5, AMCR banal gained 2.5% aft reporting Q1 fiscal 2026 results. Revenue roseate 71.3% twelvemonth implicit twelvemonth to $5.75 billion, modestly missing the $5.83 cardinal expert estimate, portion adjusted EPS reached $0.19, fundamentally matching expectations and rising 18% annually.

More importantly, net exceeded the midpoint of management’s guidance range, highlighting disciplined outgo power and improving productivity. The results besides captured the Berry concern integration, with synergies tracking astatine the precocious extremity of expectations, strengthening assurance successful management’s execution.

Looking ahead, absorption targets at slightest $260 cardinal successful synergy benefits successful fiscal 2026. Over the 3 years done fiscal 2028, synergies unsocial could thrust much than 30% EPS growth.

Industry comparisons adhd perspective, arsenic unit extends beyond Amcor. Shares of the company’s rival, Ball Corporation (BALL), also declined 12.2% implicit the past 52 weeks and fell different 7.7% YTD.